Spindle Cell Lipoma and Pleomorphic Lipoma: An Update and Review
Cancer Diagnosis & Prognosis · 02.05.2023 · 3 (3) · 282-290
DOI: 10.21873/cdp.10213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 02.05.2023. Verfasst von Yukiko Ohshima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. Die Arbeit wurde bisher 35-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Spindle cell lipoma (SCL) is a benign adipocytic tumor that primarily occurs in the subcutis of the posterior neck, upper back, and shoulder, particularly of middle-aged males. SCL and pleomorphic lipoma (PL) represent a morphological spectrum of one disease process. The lesion typically presents as a relatively small (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
- Section of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan.
- Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Zitieren
APA
Ohshima, Y., Nishio, J., Nakayama, S., Koga, K., Aoki, M., & Yamamoto, T. (2023). Spindle Cell Lipoma and Pleomorphic Lipoma: An Update and Review. Cancer Diagnosis & Prognosis, 3(3), 282-290. https://doi.org/10.21873/cdp.10213
Vancouver
Ohshima Y, Nishio J, Nakayama S, Koga K, Aoki M, Yamamoto T. Spindle Cell Lipoma and Pleomorphic Lipoma: An Update and Review. Cancer Diagnosis & Prognosis. 2023;3(3):282-290. doi:10.21873/cdp.10213
BibTeX
@article{Ohshima2023,
author = {Ohshima, Yukiko and Nishio, Jun and Nakayama, Shizuhide and Koga, Kaori and Aoki, Mikiko and Yamamoto, Takuaki},
title = {Spindle Cell Lipoma and Pleomorphic Lipoma: An Update and Review},
journal = {Cancer Diagnosis & Prognosis},
year = {2023},
volume = {3},
number = {3},
pages = {282--290},
doi = {10.21873/cdp.10213}
}
EUVIMED